Amneal Pharmaceuticals Inc Class A (AMRX)

NYSE
2.570
+0.010(+0.39%)
After Hours
2.460
-0.110(-4.28%)
- Real-time Data
  • Volume:
    942,339
  • Day's Range:
    2.530 - 2.620
  • 52 wk Range:
    1.950 - 5.130

AMRX Overview

Prev. Close
2.56
Day's Range
2.53-2.62
Revenue
2.13B
Open
2.57
52 wk Range
1.95-5.13
EPS
-0.878
Volume
942,339
Market Cap
778.71M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
915,809
P/E Ratio
-2.55
Beta
1.27
1-Year Change
-37.32%
Shares Outstanding
303,592,679
Next Earnings Date
Mar 01, 2023
What is your sentiment on Amneal Pharma A?
or
Market is currently closed. Voting is open during market hours.

Amneal Pharmaceuticals Inc Class A News

Amneal Pharmaceuticals Inc Class A Analysis

Amneal Pharmaceuticals Inc Class A Company Profile

Amneal Pharmaceuticals Inc Class A Company Profile

Employees
7000

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers Emverm, a chewable tablet for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; Rytary to treat Parkinson’s disease; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.

Read More

Analyst Price Target

Average5.100 (+98.44% Upside)
High7
Low3.5
Price2.57
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyBuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • BUY
    0
    • are you still here my Eva ?
      0
  • https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
    0
    • I think its got a shot , they make a lot of money for how cheap they are.
      0
      • 6?
        0
        • breakout up trend buy
          0
          • ready to fly
            1
            • Time to buy!
              0
              • Why did it drop 12% after a better than expected earnings report??
                0
                • I was also suprised. Anyone have any information?
                  0
                • Maybe there is some undisclosed information?
                  0
              • Paolo gerosa why you say see you at 13? Its possible to get 13? What is your opinion ?
                1
                • what's the news?
                  0